ArticleBMC cancer2015

Transcriptional profiling provides insights into metronomic cyclophosphamide-activated, innate immune-dependent regression of brain tumor xenografts.

Joshua C Doloff et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.